In one niche, the risk to women is too great
By Judy Norsigian,
The Boston Globe
| 11. 14. 2010
[Op-Ed]
Not all stem cell research is in women's best interest.
The issue of embryonic stem cell research has long been clouded by certain activists — notably those from conservative Christian groups — who seek to stop all such research because it involves destruction of an embryo. In contrast, many pro-choice women’s health advocates like my own organization have long supported most embryonic stem cell research. But there is a small subset of this research we oppose — somatic cell nuclear transfer (SCNT, also called embryo cloning or research cloning) — because of substantial concerns about health risks for the women who provide the fresh eggs that this research demands.
As part of SCNT, the nucleus of an egg (from an egg donor) is removed, and the nucleus of an adult stem cell is inserted in its place. By contrast, conventional embryonic stem cell research utilizes otherwise discarded embryos from fertility clinics, and does not require freshly harvested eggs, where women undergo the risks of egg extraction solely for research purposes. This distinction is crucial.
Because thousands of women regularly undergo...
Related Articles
By Jeffrey Gettleman and Maya Tekeli, The New York Times | 09.24.2025
For some Greenlanders, sorry isn’t enough.
The prime minister of Denmark, Mette Frederiksen, made a special visit Wednesday to Greenland’s capital, Nuuk, to apologize in person for a traumatic chapter in Greenlandic history, when Danish doctors forced birth control on...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...